YY up +2.48% percent right now. $YY High is at 83.30 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 1:02 PM

YY up +2.48% percent right now. $YY High is at 83.30 and the Low 79.80 with current volume of 938,862.

Recent News posted below.

YY YY Inc Recent Headline News

Why YY Inc. (YY) Might Surprise This Earnings Season - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:05AM CST
YY Inc. has a favorable Zacks Rank and an ESP in positive territory, thus investors might want to consider this stock ahead of earnings.
YY: 81.41 (+1.91)

Critical Alerts For Stratasys, Orexigen Therapeutics, YY, Workday and Hong Kong Television Network Released By InvestorsObserver
PR Newswire - Fri Nov 07, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for SSYS, OREX, YY, WDAY and HKTV.
OREX: 4.96 (+1.11), YY: 81.41 (+1.91), WDAY: 94.99 (+0.43), SSYS: 104.46 (+1.39), HKTV: 11.30 (+0.43)

Four China-Based Internet Stocks Near Buy Points
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
Many leading stocks continue to break out and lend support to the market's confirmed uptrend. Others continue to build bases and wait their turn. About 20% of the IBD 50 list are non-U.S. stocks below buy points or in buying range. China has four,...
QIHU: 74.26 (+2.97), WUBA: 40.46 (+0.33), VIPS: 24.45 (+1.11), BIDU: 246.29 (+9.75), YY: 81.41 (+1.91), XRS: 32.97 (+0.78), ATHM: 44.02 (+0.39), BITA: 80.87 (+1.56), BABA: 117.04 (+2.48)

Alibaba Among 4 Hot Chinese Internets Set To Report
at Investor's Business Daily - Thu Oct 30, 7:02AM CDT
With the market in confirmed uptrend again, the rising tide will lift nearly all seaworthy boats. Looking for ones that are fundamentally sound, such as YY, will yield vessels that should stay afloat long-term. Chinese search giant Baidu (BIDU),...
BIDU: 246.29 (+9.75), LNKD: 227.70 (+4.66), YY: 81.41 (+1.91), BITA: 80.87 (+1.56), ATHM: 44.02 (+0.39), BABA: 117.04 (+2.48)

YY to Announce Third Quarter 2014 Financial Results
GlobeNewswire - Mon Oct 27, 7:01AM CDT
YY Inc. (Nasdaq:YY) ("YY" or the "Company"

, a revolutionary real-time interactive social platform, today announced that it plans to release its third quarter 2014 financial results on Tuesday, November 11, 2014 after market close. The Company will hold a conference call on Tuesday, November 11, 2014 at 8:00 pm Eastern Time or Wednesday, November 12, 2014 at 9:00 am Beijing Time to discuss the financial results. Participants may access the call by dialing the following numbers:
YY: 81.41 (+1.91)

Technical Pulse on Internet Software and Services Stocks - AOL Inc., YY Inc., 58.com, SouFun Holdings, and Yelp
PR Newswire - Fri Oct 24, 7:30AM CDT
Investor-Edge has initiated coverage on the following equities: AOL Inc. (NYSE: AOL), YY Inc. (NASDAQ: YY), 58.com Inc. (NYSE: WUBA), SouFun Holdings Ltd (NYSE: SFUN), and Yelp Inc. (NYSE: YELP). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 23, 2014, the NASDAQ Composite ended at 4,452.79, up 1.60%, the Dow Jones Industrial Average advanced 1.32%, to finish the day at 16,677.90, and the S&P 500 closed at 1,950.82, up 1.23%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Information Technology Sector Index ended the day at 644.14, up 1.53%, with the index also advancing 3.15% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
WUBA: 40.46 (+0.33), YY: 81.41 (+1.91), AOL: 44.00 (+1.32), SFUN: 8.54 (+0.02), YELP: 58.76 (+0.35)

Stagnant Chinese Market Masks Growth-Stock Winners
at Investor's Business Daily - Thu Oct 23, 5:24PM CDT
Concerns about a less robust Chinese economy are growing. China reported this week that its second-quarter GDP grew 7.3%, which beat the consensus estimate of economists but fell short of the government's target of 7.5%. The increase was also the...
VIPS: 24.45 (+1.11), YY: 81.41 (+1.91), LFC: 44.20 (+0.15), CHL: 62.90 (+0.74), SFUN: 8.54 (+0.02), HAO: 27.47 (+0.43), BITA: 80.87 (+1.56), FXI: 39.35 (+0.07)

Yelp (YY) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 22, 8:48PM CDT
The following Yelp (YY) conference call took place on October 22, 2014, 04:30 PM ET. This is a transcript of that earnings call:
YY: 81.41 (+1.91)

YY Inc. to Hold 2014 Annual General Meeting on November 19, 2014
GlobeNewswire - Tue Oct 21, 7:01AM CDT
YY Inc. (Nasdaq:YY) ("YY" or the "Company"

, a revolutionary real-time interactive social platform, today announced that it will hold its 2014 annual general meeting of shareholders at 42nd Floor, Edinburgh Tower, The Landmark, 15 Queen's Road, Central, Hong Kong on November 19, 2014 at 2:00 p.m. (Hong Kong time). Holders of common shares of the Company whose names are on the register of members of the Company at the close of business on October 16, 2014 are entitled to receive notice of the annual general meeting or any adjournment or postponement thereof. Beneficial owners of the Company's American Depositary Shares ("ADSs"

are welcome to attend the annual general meeting in person.
YY: 81.41 (+1.91)

Stocks Trim Big Losses, Finish Narrowly Mixed
at Investor's Business Daily - Thu Oct 16, 3:24PM CDT
Stocks erased big early losses after responding positively to comments by St. Louis Fed President James Bullard. The Nasdaq and S&P 500 closed up fractionally, while the Dow Jones industrial average dipped 0.2%. Preliminary data showed volume...
HCA: 67.26 (+1.51), YY: 81.41 (+1.91), TNC: 74.38 (+0.31), UHS: 98.97 (+1.04), CYH: 49.63 (+1.82)

LinkedIn, YY Among 5 Stocks With Top Fundamentals
at Investor's Business Daily - Thu Oct 16, 7:02AM CDT
In the current volatile market, shares of companies that boast strong fundamentals, like Regeneron Pharmaceuticals (REGN) and Michael Kors (KORS), will likely hold up well and are the top prospects for a stock watch list. Today's Screen Of The Day is...
LNKD: 227.70 (+4.66), YY: 81.41 (+1.91), FB: 74.94 (-0.66), ALXN: 193.53 (-0.28), KORS: 69.65 (-0.30), REGN: 382.19 (+4.35)

Stocks Trim Losses But Still End Lower
at Investor's Business Daily - Wed Oct 15, 3:26PM CDT
Stocks finished lower Wednesday but ended well off steep session lows in heavy trade. The Nasdaq closed down 0.3%, the S&P 500 fell 0.8%, while the Dow Jones industrial average finished down 1.1%. Preliminary data showed volume running higher across...
VIPS: 24.45 (+1.11), YY: 81.41 (+1.91), WMT: 79.96 (+1.19), BAC: 17.32 (-0.04), SCHW: 28.74 (+0.16)

GoPro, Palo Alto Lead 5 Hot Recent IPO Stocks
at Investor's Business Daily - Wed Oct 15, 7:02AM CDT
Young companies like GoPro often demonstrate the strongest growth in their heady early days, including share price gains. Today's Screen Of The Day is Young Guns, top-rated companies that have gone public in the last 15 years. A second sorting...
AMBA: 49.13 (+1.99), GPRO: 76.07 (-2.99), EBAY: 53.77 (+0.26), YY: 81.41 (+1.91), AKAM: 61.13 (+1.00), FB: 74.94 (-0.66), TGT: 65.25 (+1.08), PANW: 109.24 (+2.22), ATHM: 44.02 (+0.39), MS: 35.63 (-0.03)

IBD 50: Medical, Internet Companies Top Q3 Estimates
at Investor's Business Daily - Mon Oct 13, 6:15PM CDT
Health care and Internet companies are expected to have some of the strongest third-quarter profit gains in the IBD 50. The consensus analyst estimates for medical leaders Gilead Sciences (GILD) and Lannett (LCI) exceed 200% growth. The June-quarter...
AMBA: 49.13 (+1.99), BIIB: 324.75 (+4.00), ACT: 245.86 (-0.05), VIPS: 24.45 (+1.11), YY: 81.41 (+1.91), SWKS: 60.87 (+0.99), FB: 74.94 (-0.66), AKRX: 35.20 (-1.39), KSU: 124.71 (+1.39), SLXP: 94.45 (+2.98), ATHM: 44.02 (+0.39), LCI: 51.23 (+1.06), ABC: 87.50 (+0.77), GILD: 107.11 (+0.66), AVGO: 85.58 (+0.54)

Video: Facebook Leads 4 Nets With Rising EPS Views
at Investor's Business Daily - Fri Oct 10, 7:02AM CDT
Internet stocks can be household names, but it's not always easy to sort out the money makers from the ones with the lifespan of a faddish cat meme. Today's Screen of the Day focuses on Leaders With Rising Estimates, highly rated stocks with soaring...
YY: 81.41 (+1.91), LNKD: 227.70 (+4.66), FB: 74.94 (-0.66), GOOGL: 558.22 (+6.40), AAPL: 109.03 (+0.02), BITA: 80.87 (+1.56)

Weakness Seen in Shutterstock (SSTK): Stock Falls 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 7:31AM CDT
Shutterstock (SSTK) fell over 5% in the last trading session amid huge volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.
YY: 81.41 (+1.91), XOXO: 14.45 (-0.05), SSTK: 79.17 (-0.01), LOV: 3.88 (+0.06)

Angie's List (ANGI) in Focus: Stock Rises 7.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 7:30AM CDT
Angie's List, Inc. (ANGI) was a big mover last session, as the company saw its shares rise over 7% on the day.
YY: 81.41 (+1.91), ANGI: 6.41 (-0.20), LOV: 3.88 (+0.06), ENT: 12.72 (-0.01)

Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb
at Investor's Business Daily - Fri Oct 03, 9:39AM CDT
Stocks got off to a healthy start Friday, after a solid job market in September sent the unemployment rate below 6% for the first time since 2008. The Nasdaq rattled off a 1.1% gain. The S&P 500 and the Dow Jones industrial average each hauled in...
YY: 81.41 (+1.91), SLXP: 94.45 (+2.98), MYL: 53.71 (+0.60), MBLY: 46.28 (-0.49)

Hain Celestial, Consol Energy, HSBC Holdings, YY and Perfect World highlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Oct 01, 8:30AM CDT
Zacks Equity Research highlights Hain Celestial (Nasdaq:HAIN-Free Report) as the Bull of the Day and Consol Energy (NYSE:CNX-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onHSBC Holdings plc (NYSE:HSBC-Free Report), YY Inc. (Nasdaq:YY-Free Report) and Perfect World Co., Ltd. (Nasdaq

WRD-Free Report).
YY: 81.41 (+1.91)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...